These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 16101581)
1. Virtual screening for anti-HIV-1 RT and anti-HIV-1 PR inhibitors from the Thai medicinal plants database: a combined docking with neural networks approach. Sangma C; Chuakheaw D; Jongkon N; Saenbandit K; Nunrium P; Uthayopas P; Hannongbua S Comb Chem High Throughput Screen; 2005 Aug; 8(5):417-29. PubMed ID: 16101581 [TBL] [Abstract][Full Text] [Related]
2. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase. Gupta P; Kumar R; Garg P; Singh IP Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846 [TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations. San Juan AA Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520 [TBL] [Abstract][Full Text] [Related]
4. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents. Cele FN; Ramesh M; Soliman ME Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700 [TBL] [Abstract][Full Text] [Related]
6. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives. Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659 [TBL] [Abstract][Full Text] [Related]
7. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones. Prabhakar YS; Rawal RK; Gupta MK; Solomon VR; Katti SB Comb Chem High Throughput Screen; 2005 Aug; 8(5):431-7. PubMed ID: 16101582 [TBL] [Abstract][Full Text] [Related]
8. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action. Vilar S; Santana L; Uriarte E J Med Chem; 2006 Feb; 49(3):1118-24. PubMed ID: 16451076 [TBL] [Abstract][Full Text] [Related]
9. Combinatorial chemistry as a tool for targeting different stages of the replicative HIV-1 cycle. Mugnaini C; Petricci E; Corelli F; Botta M Comb Chem High Throughput Screen; 2005 Aug; 8(5):387-401. PubMed ID: 16101579 [TBL] [Abstract][Full Text] [Related]
10. Design of nevirapine derivatives insensitive to the K103N and Y181C HIV-1 reverse transcriptase mutants. Saparpakorn P; Hannongbua S; Rognan D SAR QSAR Environ Res; 2006 Apr; 17(2):183-94. PubMed ID: 16644557 [TBL] [Abstract][Full Text] [Related]